Nexletol™ (Bempedoic Acid), a New LDL-C Lowering Therapy, Now Available in U.S. Pharmacies

Esperion has announced that NEXLETOL™ (bempedoic acid) is now available in pharmacies in the United States. NEXLETOL is an oral, once-daily, tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C.

To read the full press release, click here: https://www.esperion.com/investors-media/press-releases/.